These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 29343849)

  • 41. Role of Lgr5-positive cells in colorectal cancer.
    Ding H; Wang C
    Tumour Biol; 2015 Sep; 36(9):6759-64. PubMed ID: 25835970
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cepharanthine exhibits a potent anticancer activity in p53-mutated colorectal cancer cells through upregulation of p21Waf1/Cip1.
    Rattanawong A; Payon V; Limpanasittikul W; Boonkrai C; Mutirangura A; Wonganan P
    Oncol Rep; 2018 Jan; 39(1):227-238. PubMed ID: 29138869
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Establishment and characterization of 13 human colorectal carcinoma cell lines: mutations of genes and expressions of drug-sensitivity genes and cancer stem cell markers.
    Ku JL; Shin YK; Kim DW; Kim KH; Choi JS; Hong SH; Jeon YK; Kim SH; Kim HS; Park JH; Kim IJ; Park JG
    Carcinogenesis; 2010 Jun; 31(6):1003-9. PubMed ID: 20176655
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Identifications and Clinical Implications of Cancer Stem Cells in Colorectal Cancer.
    Wahab SMR; Islam F; Gopalan V; Lam AK
    Clin Colorectal Cancer; 2017 Jun; 16(2):93-102. PubMed ID: 28237538
    [TBL] [Abstract][Full Text] [Related]  

  • 45. DNA damage-induced ephrin-B2 reverse signaling promotes chemoresistance and drives EMT in colorectal carcinoma harboring mutant p53.
    Alam SK; Yadav VK; Bajaj S; Datta A; Dutta SK; Bhattacharyya M; Bhattacharya S; Debnath S; Roy S; Boardman LA; Smyrk TC; Molina JR; Chakrabarti S; Chowdhury S; Mukhopadhyay D; Roychoudhury S
    Cell Death Differ; 2016 Apr; 23(4):707-22. PubMed ID: 26494468
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Trp53 null and R270H mutant alleles have comparable effects in regulating invasion, metastasis, and gene expression in mouse colon tumorigenesis.
    Tang J; Feng Y; Kuick R; Green M; Green M; Sakamoto N; Kurosu Y; Lin J; Cho KR; Fearon ER
    Lab Invest; 2019 Oct; 99(10):1454-1469. PubMed ID: 31148594
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intestinal cancer progression by mutant p53 through the acquisition of invasiveness associated with complex glandular formation.
    Nakayama M; Sakai E; Echizen K; Yamada Y; Oshima H; Han TS; Ohki R; Fujii S; Ochiai A; Robine S; Voon DC; Tanaka T; Taketo MM; Oshima M
    Oncogene; 2017 Oct; 36(42):5885-5896. PubMed ID: 28628120
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic role of p53 messenger ribonucleic acid expression in patients after curative resection for stage I to III colorectal cancer: association with colon cancer stem cell markers.
    Huh JW; Kim HR; Kim YJ
    J Am Coll Surg; 2013 Jun; 216(6):1063-9. PubMed ID: 23571142
    [TBL] [Abstract][Full Text] [Related]  

  • 49. FBXW7-mutated colorectal cancer cells exhibit aberrant expression of phosphorylated-p53 at Serine-15.
    Li N; Lorenzi F; Kalakouti E; Normatova M; Babaei-Jadidi R; Tomlinson I; Nateri AS
    Oncotarget; 2015 Apr; 6(11):9240-56. PubMed ID: 25860929
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Special AT-rich sequence-binding protein 2 acts as a negative regulator of stemness in colorectal cancer cells.
    Li Y; Liu YH; Hu YY; Chen L; Li JM
    World J Gastroenterol; 2016 Oct; 22(38):8528-8539. PubMed ID: 27784965
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Overexpression of HOXA4 and HOXA9 genes promotes self-renewal and contributes to colon cancer stem cell overpopulation.
    Bhatlekar S; Viswanathan V; Fields JZ; Boman BM
    J Cell Physiol; 2018 Feb; 233(2):727-735. PubMed ID: 28464221
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CD49f-positive cell population efficiently enriches colon cancer-initiating cells.
    Haraguchi N; Ishii H; Mimori K; Ohta K; Uemura M; Nishimura J; Hata T; Takemasa I; Mizushima T; Yamamoto H; Doki Y; Mori M
    Int J Oncol; 2013 Aug; 43(2):425-30. PubMed ID: 23708747
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Distinctive patterns of p53 protein expression and microsatellite instability in human colorectal cancer.
    Nyiraneza C; Jouret-Mourin A; Kartheuser A; Camby P; Plomteux O; Detry R; Dahan K; Sempoux C
    Hum Pathol; 2011 Dec; 42(12):1897-910. PubMed ID: 21665242
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Expression Analysis of Intestinal Cancer Stem Cell Marker Lgr5 in Colorectal Cancer Patients and the Correlation with Histopathological Markers.
    Salehzadeh S; Hasanzad M; Kadijani AA; Akbari A
    J Gastrointest Cancer; 2020 Jun; 51(2):591-599. PubMed ID: 31422541
    [TBL] [Abstract][Full Text] [Related]  

  • 55. DEAD box protein DDX1 promotes colorectal tumorigenesis through transcriptional activation of the LGR5 gene.
    Tanaka K; Ikeda N; Miyashita K; Nuriya H; Hara T
    Cancer Sci; 2018 Aug; 109(8):2479-2489. PubMed ID: 29869821
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mutant KRAS promotes liver metastasis of colorectal cancer, in part, by upregulating the MEK-Sp1-DNMT1-miR-137-YB-1-IGF-IR signaling pathway.
    Chu PC; Lin PC; Wu HY; Lin KT; Wu C; Bekaii-Saab T; Lin YJ; Lee CT; Lee JC; Chen CS
    Oncogene; 2018 Jun; 37(25):3440-3455. PubMed ID: 29559746
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mutant p53 accumulation in human breast cancer is not an intrinsic property or dependent on structural or functional disruption but is regulated by exogenous stress and receptor status.
    Bouchalova P; Nenutil R; Muller P; Hrstka R; Appleyard MV; Murray K; Jordan LB; Purdie CA; Quinlan P; Thompson AM; Vojtesek B; Coates PJ
    J Pathol; 2014 Jul; 233(3):238-46. PubMed ID: 24687952
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reduced CD146 expression promotes tumorigenesis and cancer stemness in colorectal cancer through activating Wnt/β-catenin signaling.
    Liu D; Du L; Chen D; Ye Z; Duan H; Tu T; Feng J; Yang Y; Chen Q; Yan X
    Oncotarget; 2016 Jun; 7(26):40704-40718. PubMed ID: 27302922
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cancer stem cell-associated miRNAs serve as prognostic biomarkers in colorectal cancer.
    Toden S; Kunitoshi S; Cardenas J; Gu J; Hutchins E; Van Keuren-Jensen K; Uetake H; Toiyama Y; Goel A
    JCI Insight; 2019 Mar; 4(6):. PubMed ID: 30895943
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transcriptional repression of cancer stem cell marker CD133 by tumor suppressor p53.
    Park EK; Lee JC; Park JW; Bang SY; Yi SA; Kim BK; Park JH; Kwon SH; You JS; Nam SW; Cho EJ; Han JW
    Cell Death Dis; 2015 Nov; 6(11):e1964. PubMed ID: 26539911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.